What is Survanta, and how does it work?
Xermelo is indicated for the treatment of carcinoid syndrome diarrhea, which is diarrhea caused by cancerous tumors, in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy.
What are the side effects of Survanta?
Clinical Trials Experience
Because clinical trials are conducted under widely varying conditions, adverse reaction rates observed in the clinical trials of a drug cannot be directly compared to rates in the clinical trials of another drug and may not reflect the rates observed in practice.
- Xermelo was studied in a double-blind, placebo-controlled clinical trial of 90 patients with metastatic neuroendocrine tumors and carcinoid syndrome diarrhea.
- Patients reported between 4 to 12 bowel movements daily despite the use of SSA therapy at a stable dose for at least 3 months. Placebo or Xermelo 250 mg was administered three times daily for 12 weeks.
- Concomitant anti-diarrheal medications (e.g., loperamide) were used by 43% (36% and 51% in the placebo and Xermelo group, respectively), pancreatic enzyme replacement medications by 39% (36% and 42% in the placebo and Xermelo group, respectively), and opioid analgesics by 29% (24% and 33% in the placebo and Xermelo group, respectively) of patients during the 12-week double-blind period of the trial.
Table 1 below lists adverse reactions occurring at an incidence of at least 5% in the Xermelo group (N=45) and at an incidence greater than placebo (N=45) during the 12-week placebocontrolled period of the trial.
Table 1: Percent Common Adverse Reactionsa by
Treatment Group at 12-Weeks in a Double-Blind Placebo-Controlled Clinical Trial
of Patients with Carcinoid Syndrome Diarrhea
|Adverse Reaction||Xermelo 250 mg Three Times Daily,
|Increased gamma-glutamyl-transferase (GGT)||9||0|
|a incidence of at least 5% in the Xermelo
group and at an incidence greater than placebo
b including depression, depressed mood and decreased interest
In another placebo-controlled clinical trial of patients with carcinoid syndrome diarrhea and less than 4 bowel movements per day, the following additional adverse reactions, not listed in Table 1, of abdominal pain (including upper and lower abdominal pain, abdominal distention and gastrointestinal pain) and constipation were reported in at least 5% of patients in the Xermelo treated group and at an incidence greater than placebo.
Less Common Adverse Reactions
The following is a list of adverse reactions occurring in less than 5% of patients receiving Xermelo during the 12-week placebo-controlled period of the clinical trial:
Fecaloma was reported in one patient treated with Xermelo during the 36-week open-label extension period following the 12-week double-blind period of the trial.
What is the dosage for Survanta?
The recommended dosage of Xermelo in adult patients is 250 mg three times daily for patients whose diarrhea is inadequately controlled by SSA therapy.
- Take Xermelo with food.
- When short-acting octreotide is used in combination with Xermelo, administer shortacting octreotide at least 30 minutes after administering Xermelo.
- If a dose is missed, take the next dose at the regular time. Do not take 2 doses at the same time to make up for a missed dose.
- Discontinue Xermelo if severe constipation develops.
What drugs interact with Survanta?
- Concomitant use of Xermelo may decrease the efficacy of drugs that are CYP3A4 substrates (e.g., midazolam) by decreasing their systemic exposure.
- Monitor for suboptimal efficacy and consider increasing the dose for concomitant CYP3A4 substrates, if necessary.
- Concurrent administration of short-acting octreotide with Xermelo significantly decreased the systemic exposure of telotristat ethyl and telotristat, the active metabolite.
- If treatment with short-acting octreotide is needed in combination with Xermelo, administer short-acting octreotide at least 30 minutes after administration of Xermelo.
Is Survanta safe to use while pregnant or breastfeeding?
- There are no human data with Xermelo use in pregnant women to inform a drug-associated risk.
- There are no data on the presence of telotristat ethyl in human or animal milk, the effects on the breastfed infant, or the effects on milk production.
- The effects of local gastrointestinal and systemic exposure to telotristat ethyl on breastfed infants are unknown.
- The developmental and health benefits of breastfeeding should be considered along with the mother's clinical need for Xermelo and any potential adverse effects on the breastfed infant from Xermelo or from the underlying maternal condition.
Xermelo is a prescription medication used to treat carcinoid syndrome diarrhea, which is diarrhea caused by cancerous tumors, in combination with somatostatin analog (SSA) therapy in adults inadequately controlled by SSA therapy. Side effects of Xermelo include nausea, headache, increased gamma-glutamyl-transferase (GGT), depression, peripheral edema, flatulence, decreased appetite, and pyrexia.
Multimedia: Slideshows, Images & Quizzes
Colorectal (Colon) Cancer Quiz: Test Your Medical IQ
What is colorectal (colon) cancer and who gets it? Take this quiz to find out how this disease may be prevented.
Top 10 Cancers Quiz
Take this quiz to learn the causes of cancer. Get the facts about the causes, symptoms, and treatments for the world's most...
Gastric Cancer Quiz
What are the main risk factors for gastric cancer? Where does gastric cancer occur? Take this quiz to learn about this different...
Picture of Pancreatic Cancer Tumor
This is a gross section of a malignant tumor of the pancreas resected from the pancreatic body and tail. See a picture of...
Colon Cancer: Symptoms, Signs, Screening, Stages
Colorectal cancer (colon cancer) is the cause of many cancer deaths. Learn about the warning signs, symptoms, screening process,...
Cancer-Fighting Foods: Resveratrol, Green Tea, and More
Experts have praised certain foods for their ability to reduce cancer risks. Learn which foods and eating strategies may help...
Signs of Cancer in Men: Could it Be Cancer?
See pictures of which 15 cancer symptoms men ignore such as skin changes, difficulty swallowing, rapid weight loss, a breast...
Signs of Cancer in Women: Symptoms You Can't Ignore
Cancer symptoms can surprise women if they don't know what to watch out for. 15 cancer symptoms women ignore such as weight loss,...
Gastric (Stomach) Cancer: Types, Causes, Symptoms, Treatment
What are the common signs and symptoms of stomach cancer? Learn about gastric cancer diagnosis, treatment, and their risks, how...
Colon Cancer: How Your Diet Can Affect Colorectal Cancer
Diet, including nutrient, antioxidant, and vitamin intake, affects colon cancer risk. Certain dietary factors either decrease or...
Cancer: Guide to Leukemia
Learn about the common types and stages of leukemia, who gets it, symptoms, tests, treatments, and more. People with blood cancer...
Cancer: How to Lower and Cut Your Risk of Cancer
About a third of all cases of cancer can be prevented. Find out how to lower your chances of getting it.
Cancer: Visual Guide to Thyroid Cancer
Find out the symptoms of thyroid cancer, and learn how to treat it after you get a diagnosis.
Cancer: Cancer 'Remedies' That Don't Work
You may have read about an all-natural cure for cancer. While many therapies are helpful, some aren't worth your time or money....
Cancer: Does This Cause Cancer?
Everything gives you cancer, right? Not really. WebMD's slide show tells you about the research into cancer and cell phones,...
Related Disease Conditions
Carcinoid Syndrome (Carcinoid Tumor)
A carcinoid tumor is a tumor that develops from enterochromaffin cells. The important characteristic of carcinoid tumors that sets them apart from other gastrointestinal tract tumors, is their potential to cause the carcinoid syndrome. Local symptoms may include abdominal pain, intestinal bleeding, flushing., gastrointestinal bleeding, and diarrhea. Often, symptoms of the carcinoid syndrome can be more devastating than the local symptoms. There are many options for the treatment of carcinoid tumors and carcinoid syndrome.
Tumor grade is a system used to classify cancer cells in how likely the tumor is to grow and how abnormal they look under a microscope. Tumor grade is not the same as tumor stage. A biopsy is taken to determine if the tumor is benign (non cancerous) or malignant (cancerous).
Treatment & Diagnosis
- Cancer Research: Going the Distance
- Colon Cancer Update with The Cleveland Clinic
- Cancer and Green Tea
- Colorectal Cancer Issues: An Update with Doctors
- Cancer Pain Management with Ann Reiner
- Cancer: The Importance of Joining a Cancer Support Group with Selma Schimmel
- Cancer Patients Need Proper Diet and Exercise
- Cancer: Living Well Despite with Win Boerckel
- Cancer Treatment: Writing to Heal with Margie Davis
- Cancer Survival and Attitude with Hamilton Jordan
- Cancer: Childhood Cancer Survivors
- Colon Cancer Update: James Church, MD
- Cancer: Confronting Cancer with Humor
- Cancer: Journaling to Save Your Life
- Cancer: Emotional Aftershocks: When Cancer Comes Back 10/30/02
- Colon Cancer Update
- Colon Cancer
- Carcinoid Syndrome
- Cancer FAQs
- Gastric Cancer FAQs
- Colorectal (Colon) Cancer FAQs
- Cancer,Stroke & Heart Attack Risks- ReducedThrough Walking
- Colon Cancer Prevention And Fiber?
- Cancer Care in the Elderly
- Colon Cancer and Polyp Screening Guidelines
- Cancer Survivor?
- Colon Cancer Silences Howard Keel
- Colon Cancer, The Genetic Factor
- 10 Cancer Symptoms That Men Ignore
- Cancer Prevention: The Anticancer Diet
Medications & Supplements
Latest Cancer News
Daily Health News
Health Solutions From Our Sponsors
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.